CRYO FREE 47T ACTIVE SHIELDED ICR SPECTROMETER MAGNET

该项目旨在开发具有主动屏蔽功能的4.7特斯拉无低温高分辨率傅立叶变换质谱仪磁体原型。采用闭式循环制冷，大大降低了系统的运行成本和运行复杂度。所提出的磁体系统将是理想的生物实验室进行频谱分析，在哪里和何时访问液冷剂是有限的，或在实验室空间有限。第一阶段的研究目标是证明建立一个全尺寸原型FTMS无低温磁体的可行性。为了实现这一目标，crymagnetics提出了一种技术方法，包括在无低温环境下测试模型线圈在持续模式下的稳定性，并将其与淬火保护电路集成以测试整个模型。将开发原型4.7T高分辨率FTMS磁体的全尺寸工程设计，这将是原型4.7T磁体的第二阶段计划制造的起点。在第一及第二阶段发展的新技术，可减低FTMS系统的运作成本及增加灵活性，对商业产生重大影响。该项目二期工程的顺利完成将使流动性高；高分辨率FTMS磁体在市场上可用。拟议的商业应用：拟议的FTMS磁体提供的更高的灵敏度，光谱分辨率迁移率和降低的操作成本将以非侵入性的方式产生更详细的生物信息。这个项目的成功完成将有助于美国公司在这个快速增长的，每年20亿美元的全球市场上竞争。

This project is aimed at developing a prototype 4.7 tesla cryogen-free high resolution Fourier Transform Mass Spectrometer magnet with an active-shield feature. By using closed cycle refrigeration, system operating cost and the operating complexity will be reduced significantly. The proposed magnet system will be ideal for bio-laboratories to perform spectrum analysis where and when access to liquid cryogens is limited, or where the laboratory space is limited. The Phase I research objective are to demonstrate the feasibility of building a full scale prototype FTMS cryogen-free magnet. To achieve the objectives, Cryomagnetics proposes a technical approach consisting of testing the stability of model coil under persistent mode operation in a cryogen-free environment and integrating it with quench protection circuits to test the complete model. A full scale engineering design of the prototype 4.7T high resolution FTMS magnet will be developed which will be the starting point for Phase II program fabrication of the prototype 4.7T magnets. The new technologies developed in Phase I and II will generate great commercial impact by reducing FTMS system operating cost and increasing flexibility. The successful completion of Phase II of this project will make high mobility; high resolution FTMS magnets available in the market. PROPOSED COMMERCIAL APPLICATION: The increased sensitivity, spectral resolution mobility and reduced the operating cost which the proposed FTMS magnet offer will yield more detailed biological information in a non-invasive manner. The successful completion of this project will help American companies to compete in this fast-growing, $2 billion/annual worldwide market.